ArticleInternational ophthalmology2025
Investigation of protective effect of carvacrol in an experimental cataract model.
Article in International ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the protective effect of carvacrol in an experimental cataract model in rats. MATERIAL AND
methodsIn this study, twenty-one Sprague Dawley rat pups were randomly assigned to form three groups. Group 1 (control) received a subcutaneous dimethyl sulfoxide (DMSO) solution and served as the control group. Group 2 (selenite) received only subcutaneous sodium selenite (30 nmol/g) and DMSO solution, and, Group 3 (treatment) received subcutaneous sodium selenite and a single intraperitoneal dose of carvacrol (33.3 mg/kg). In all groups, injections were administered as a single dose on postnatal day 10. Cataract formation was evaluated on the 10th day after injection, and cataract grading was made. Morphological examination, quantitative analyses of antioxidant concentrations, oxidative stress markers, Ca
resultsThe mean cataract stages in control, selenite and treatment groups were 0.00 ± 0.00, 3.71 ± 0.75, and 1.71 ± 0.48 respectively. There was a statistically difference between the mean cataract stages of control and selenite groups. (p< 0.01) The mean cataract stages of treatment group were significantly reduced compared with selenite group. (p < 0.01) When selenite and treatment groups were compared, in treatment group, antioxidant activity (p < 0.01) and Ca ATPase pump activity (p < 0.01) increased, while oxidative stress markers, Ca
conclusionThe results of the present study suggest that carvacrol administration, owing to its potent antioxidant and anti-apoptotic properties, might attenuate selenite-induced cataractogenesis through multiple mechanisms that are involved in cataract development.
Indexed as
Identifiers
41134385What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.